RooLife (“RLG”) is continuing to grow its reputation as a global leader in helping companies expand into China, this time scoring a deal to help UK companies enter one of the largest and fastest growing middle-class markets in the world.

China-focused digital marketing and e-commerce company RooLife Group (ASX:RLG) has been appointed by Santander UK, as the China entry provider for UK companies looking to expand globally as part of Santander Navigator, a digital subscription platform.

The Santander Navigator portal is an online platform to assist and manage new market entry for UK businesses, connecting them to new markets.

RLG’s role will be to support, manage and implement Chinese market roll outs for suitable and selected businesses.

RLG and Santander UK will launch the first China entry program online and at an event in the UK in September 2022.

The two companies are firstly focusing on UK based health and wellbeing brands looking to launch their products in China, with successful brands to be selected in October 2022.

Navigator platform a global first

Santander UK head of international and transactional banking John Carroll believes the company’s Navigator platform is a global first.

“It is a true end-to-end proposition to support businesses on their international growth journey and a fantastic example of how we’re innovating and introducing digital solutions that make businesses’ lives easier,” Carroll said.

RLG Managing Director Bryan Carr said the company was excited to partner with an organisation of the calibre of Santander.

“With its established global banking footprint and over 150 million customers, the Santander Navigator portal and technology nicely complements RLG’s Marketplace which is designed to match consumer demand with suppliers globally, with a focus on servicing the high demand for international products in China,” he said.

“Products from the UK are held in high regard with Chinese consumers and our experience in operating in China coupled with Santander’s reach and strong established relationships with businesses, forms a powerful go-to-market strategy to grow transaction value between UK based businesses and China, initially and then globally as this relationship develops.”

Commercial benefits to all

RLG can’t determine exact revenues expected to flow from the partnership. However, the addition of the significant channel to market with introductions to mature, export-ready businesses specifically seeking to enter the China market is expected to deliver commercial benefits to all parties involved.

It’s been a good start to 2023 for RLG which has joined with  AFT Pharmaceuticals (ASX:AFP) to establish and operate the first New Zealand over the counter (OTC) online pharmacy store inside China under a potentially lucrative pilot scheme.

Following registration under China’s cross border e-commerce (CBEC) OTC pilot scheme, the store has become the first dedicated direct to consumer OTC online medicine marketplace for New Zealand registered medicines.

This article was developed in collaboration with Roolife, a Stockhead advertiser at the time of publishing.  

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.